Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENOXAPARIN Cause Ovarian hyperstimulation syndrome? 35 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Ovarian hyperstimulation syndrome have been filed in association with ENOXAPARIN (Enoxaparin Sodium). This represents 0.1% of all adverse event reports for ENOXAPARIN.

35
Reports of Ovarian hyperstimulation syndrome with ENOXAPARIN
0.1%
of all ENOXAPARIN reports
1
Deaths
35
Hospitalizations

How Dangerous Is Ovarian hyperstimulation syndrome From ENOXAPARIN?

Of the 35 reports, 1 (2.9%) resulted in death, 35 (100.0%) required hospitalization.

Is Ovarian hyperstimulation syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENOXAPARIN. However, 35 reports have been filed with the FAERS database.

What Other Side Effects Does ENOXAPARIN Cause?

Off label use (1,707) Exposure during pregnancy (1,215) Haemorrhage (1,059) Foetal exposure during pregnancy (918) Anaemia (914) Thrombocytopenia (834) Dyspnoea (822) Maternal exposure during pregnancy (818) Drug ineffective (769) Nausea (708)

What Other Drugs Cause Ovarian hyperstimulation syndrome?

CHORIOGONADOTROPIN ALFA (1,016) FOLLITROPIN (718) GANIRELIX (672) TRIPTORELIN (356) PROGESTERONE (293) MENOTROPINS (238) LUTROPIN ALFA (194) GONADOTROPHIN, CHORIONIC (173) FOLLITROPIN BETA (163) FOLLITROPIN ALFA (138)

Which ENOXAPARIN Alternatives Have Lower Ovarian hyperstimulation syndrome Risk?

ENOXAPARIN vs ENOXAPARIN - WINTHROP ENOXAPARIN vs ENSIFENTRINE ENOXAPARIN vs ENTACAPONE ENOXAPARIN vs ENTECAVIR ENOXAPARIN vs ENTINOSTAT

Related Pages

ENOXAPARIN Full Profile All Ovarian hyperstimulation syndrome Reports All Drugs Causing Ovarian hyperstimulation syndrome ENOXAPARIN Demographics